DAY 1 – FRIDAY, OCTOBER 4, 2019 | ||
|
||
Time |
Topic |
Faculty |
7:45 am |
Check-in/Registration, Breakfast & Product Education |
|
8:40 am |
Welcome and Opening Remarks |
Gary Chien, MD |
Sexual Medicine |
||
8:50 am |
Male Orgasmic Disorders |
Alan Shindel, MD |
9:20 am |
Updates in Management of Acute Phase Peyronie’s Disease |
John Muhall, MD |
9:50 am |
Erectile Dysfunction in Unusual Populations |
Alan Shindel, MD |
10:20 am |
BREAK (15 minutes) |
|
10:35 am |
The Hypogonadal Man – AUA Testosterone Guidelines |
John Muhall, MD |
11:05 am |
Panel Q & A |
John Muhall, MD |
11:40 am |
Reflective Discussion |
Christopher Tenggardjaja, MD |
12:00 pm |
LUNCH |
|
Upper Tract Oncology |
||
1:00 pm |
Update on Early Stage Testes Cancer Management |
Sia Daneshmand, MD |
1:30 pm |
The role of surgery in locally advanced and metastatic kidney cancer in 2019 |
Viraj Master, MD, PhD |
2:00 pm |
Cancer Management and Update on Quality of Care for Testes Cancer |
Sia Daneshmand, MD |
2:30 pm |
Frailty Assessments: Why is it important? |
Viraj Master, MD, PhD |
3:00 pm |
BREAK (15 minutes) |
|
3:15 pm |
Panel Q & A |
Sia Daneshmand, MD |
3:45 pm |
Residents Research |
Ramzi Jabaji, MD |
4:15 pm |
Adjournment for the day |
Gary Chien, MD |
|
||
DAY 2 – SATURDAY, OCTOBER 5, 2019 | ||
|
||
Time |
Topic |
Faculty |
6:30 am |
Check-in for Pre-Session & Breakfast |
|
7:30 am |
Check-in/Registration, Breakfast, Product Education |
|
8:35 am |
Day 2 Welcome and Overview |
Gary Chien MD |
Stones |
||
8:40 am |
Medical Management of Stone Disease |
Michael Lipkin, MD |
9:10 am |
PCNL Access |
Roger Sur, MD |
9:45 am |
2019 Update on PCNL |
Roger Sur, MD |
10:15 am |
BREAK (15 minutes) |
|
10:30 am |
Ureteroscopic Stone Management: Dusting vs |
Michael Lipkin, MD |
11:00 am |
Update on Medical Expulsive Therapy |
Michael Lipkin, MD |
11:30 am |
Update on SCPMG Healthy Stones Protocol |
Reza Goharderakhshan, MD |
12:00 pm |
LUNCH |
|
Lower Tract Oncology |
||
1:00 pm |
Current Management of Superficial Bladder Cancer |
Michael O’Donnell, MD |
1:40 pm |
Update on Immunotherapy in Bladder Cancer |
Helen Moon, MD |
2:20 pm |
Technical Considerations of Bladder Cancer |
Michael O’Donnell, MD |
3:00 pm |
BREAK (15 minutes) |
|
3:15 pm |
Panel |
Michael O’Donnell, MD |
3:45 pm |
SCPMG Urologic Oncology Guidelines: Confirm MDX I: Utilization |
David Finley, MD |
3:45 pm |
SCPMG Urologic Oncology Guidelines: Confirm MDX II: Concordance with prostate MRI |
David Finley, MD |
4:15 PM |
Meeting Adjourned |
Gary Chien, MD |